Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation

Harald M. H. G. Albers(The Netherlands Cancer Institute), Huib Ovaa(Leiden University Medical Center), Olaf van Tellingen(Dutch Cancer Society), Erica W. van Tilburg(Institute of Cell Biology), Andrew J. Morris(Central Arkansas Veterans Healthcare System), Laurens A. van Meeteren(The Netherlands Cancer Institute), Wouter H. Moolenaar(Oncode Institute), Manjula Sunkara(University of Kentucky), Susan S. Smyth(University of Kentucky), Anping Dong(First Affiliated Hospital of Xi'an Jiaotong University), David A. Egan(Genesis Foundation), Karianne Schuurman(The Netherlands Cancer Institute)
Proceedings of the National Academy of Sciences
April 1, 2010
10.1073/pnas.1001529107
Cited by 207

Related Papers

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
|Cell|1994|2.3k
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884
Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C.
|PubMed|2002|688